Organigram Holdings Inc. OGI
Annual
Quarterly
No annual revenue total was found in ORGANIGRAM HOLDINGS INC.'s SEC filings.
Organigram Holdings Inc. (OGI) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
108.59M
-63.7% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OGI (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1620737
- Former names
- ORGANIGRAM HOLDINGS INC. (until Apr 1, 2025); ORGANIGRAM HOLDINGS INC (until Jul 21, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 3, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 1, 2026 | Feb 18, 2026 |
| 6-K | Current report (foreign issuer) | Aug 20, 2026 | Aug 20, 2026 |
All 321 Organigram Holdings Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.